Endostatin: are we waiting for Godot?
Whitworth
Ariel
A
D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D043169:Endostatins / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D012107:Research Design
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D043169:Endostatins